Clinical Trials Sponsored by Ulthera, Inc

Total 35772 results

Bio-Thera Solutions
Peking University Cancer Hospital & Institute

Recruiting

Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT4706 in Advanced Solid Tumors

Melanoma | Advanced Solid Tumor

China
Thomas Kuhnt
Verband Deutscher Druckkammerzentren

Terminated

Hyperbaric Oxygen for the Treatment of a Dry Mouth Which Occurred After Radiotherapy

Radiation-induced Xerostomia

Germany
NC Medial Research Inc

Recruiting

A Study of NCS-01 in Patients With Acute Ischemic Stroke

Ischemic Stroke

United States
IC-IT Sciences Inc.

Unknown

Comparison of the Natural Frequencies Technology Sleep Patches to Sham Patches During Sleep in the Home Environment

Sleep Disturbance

United States
Martin-Luther-Universität Halle-Wittenberg
Otto-von-Guericke University Magdeburg

Completed

Optimization of the Healing Process of the Uterine Scar Tissue After Re-cesarean Section (OPSTAR)

Scar; Previous Cesarean Section | Complications; Cesarean Section, Wound, Dehiscence

Germany
Dr. Petra Tschanter
BioLineRx, Ltd.

Unknown

BL-8040 Addition to Consolidation Therapy in AML Patients (BLAST)

Acute Myeloid Leukemia

Germany
Martin-Luther-Universität Halle-Wittenberg
Deutsche Krebshilfe e.V., Bonn (Germany)

Completed

Somatic-psychosocial Care Concept for Oncologic Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)

Malnutrition | Oral Mucositis

Germany
Haydom Lutheran Hospital
Bill and Melinda Gates Foundation; University of Virginia

Completed

Early Life Interventions for Childhood Growth and Development In Tanzania (ELICIT)

Malnutrition | Stunting | Cognitive Development | Enteric Pathogens

Tanzania
OxThera
FP7-SME-2013 Research for the benefit of SMEs program

Completed

Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Patients With Primary Hyperoxaluria

Primary Hyperoxaluria

France, Germany, United Kingdom
Zhengzhou Gensciences Inc
Haimen Gensciences lnc

Completed

An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A.

Hemophilia A

China
Zhengzhou Gensciences Inc
Jiangsu Gensciences lnc.

Completed

Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A (RH-107-III02)

Hemophilia A

China
PD Dr. med. Matthias Dollinger

Unknown

Sorafenib Plus Doxorubicin Versus Sorafenib Alone for the Treatment of Advanced Hepatocellular Carcinoma: a Randomized Phase II Trial (SoraDox)

Liver Carcinoma

Germany
Changhai Hospital
Shanghai Ultra-T Immune Therapeutics Co. LTD

Not yet recruiting

A Clinical Study on the Safety and Efficacy of CAR-T Therapy for the TM4SF1-positive Tumors of Digestive System

Digestive Tumor
Bio-Thera Solutions
The First Hospital of Jilin University

Completed

A Study on Pharmacokinetics and Safety of BAT2506 Injection Versus Simponi®

Psoriatic Arthritis

China
Martin-Luther-Universität Halle-Wittenberg
Hannover Medical School; University of Leipzig

Not yet recruiting

Reduction of Polypharmacy in Elderly People With Multiple Diseases (RED)

Multimorbidity | Polypharmacy
University of Vienna
University of Lausanne; Martin-Luther-Universität Halle-Wittenberg

Completed

Praxis Evaluation of a Pain Self-management Support Intervention for Oncology Patients: A Stepped Wedge Design Study (EvANtiPain)

Cancer Pain Self-management

Austria
William Evans
Georgia Southern University; Health Association of Niagara County, Inc.; Catholic... and other collaborators

Recruiting

Evaluating the Impact of Senior Companion Programs

Aging | Disabilities Multiple

United States
UNC Lineberger Comprehensive Cancer Center
Seagen Inc.

Completed

Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma

Hodgkin Lymphoma, Adult

United States
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Terminated

Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids (NRR)

Graft Versus Host Disease

United States
Heart and Diabetes Center North-Rhine Westfalia
Martin-Luther-Universität Halle-Wittenberg

Completed

Patient-related Effects of Primary Nursing (ENGAGE)

Nurse's Role

Germany
Addis Ababa University
Charite University, Berlin, Germany; Martin-Luther-Universität Halle-Wittenberg

Unknown

Optimizing Cervical Cancer Screening Modalities

Cervical Cancer
Martin-Luther-Universität Halle-Wittenberg
University of Luebeck; University of Witten/Herdecke

Completed

Effect of Person-Centred-Care on Antipsychotic Drug Use in Nursing Homes: a Cluster-randomised Trial (EPCentCare)

Dementia

Germany
Martin-Luther-Universität Halle-Wittenberg
University of Giessen; German Cancer Aid

Unknown

Social Inequalities in the Participation and Activity in Children and Adolescents With Hodgkin-lymphoma

Classical Hodgkin Lymphoma
UNC Lineberger Comprehensive Cancer Center
Veracyte, Inc.

Recruiting

Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA (HARMONY)

Breast Cancer

United States
UNC Lineberger Comprehensive Cancer Center
Seagen Inc.

Active, not recruiting

BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma

Lymphoma | Lymphatic Diseases | Adult T-Cell Leukemia/Lymphoma

United States
IGC Pharma LLC

Completed

Study of IGC-AD1 in Subjects With Dementia Due to Alzheimer's Disease

Dementia of Alzheimer Type

Puerto Rico
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Completed

Cancer Patients' Performance Status Assessed Using Cardiopulmonary Exercise Testing and Wearable Data Generation

Hematologic Malignancies | Malignant Solid Tumor

United States
IGC Pharma LLC

Recruiting

IGC-AD1 Trial on Agitation in Dementia Due to Alzheimer's (IGC-AD1-P2)

Aggression | Depression | Anxiety | Alzheimer Disease | Memory Impairment | Agitated; State, Acute Reaction to Stress | Agitation,Psychomotor | Care Giving Burden | NPS | Aggressive Outburst

United States, Canada, Puerto Rico
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Recruiting

Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma

Diffuse Large B-cell Lymphoma

United States
Hans-Joachim Schmoll, MD
Biocompatibles UK Ltd

Terminated

TACE With Irinotecan Drug-eluting Beads and Intravenous (IV) Cetuximab in Refractory Colorectal Cancer (DEBIRITUX)

Colorectal Cancer

Germany
Martin-Luther-Universität Halle-Wittenberg
German Federal Ministry of Education and Research

Completed

Effective Strategies for Dementia Care (WISDE)

Cognitive Impairment | Dementia

Germany
Martin-Luther-Universität Halle-Wittenberg
German Federal Ministry of Education and Research

Completed

Structured Information During the Intensive Care Unit Stay

Anxiety

Germany
Martin-Luther-Universität Halle-Wittenberg
German Federal Ministry of Education and Research

Completed

Growing Old at Home

Aging

Germany
Savannas Forever Tanzania
National Institute for Medical Research, Tanzania; Arusha Lutheran Medical...

Unknown

Impact Evaluation Study of The Faithful House Programme on Violence Reduction in Families (TFHEVAL)

Child Maltreatment

Tanzania
Novan, Inc.
Synteract, Inc.; Therapeutics, Inc.

Completed

A Phase 3 Molluscum Contagiosum Efficacy and Safety Study (B-SIMPLE4)

Molluscum Contagiosum

United States
Martin-Luther-Universität Halle-Wittenberg
State University of New York - Downstate Medical Center

Completed

Circadian Rhythm of Blood Lactate

Healthy

Germany
Martin-Luther-Universität Halle-Wittenberg
German Federal Ministry of Education and Research

Completed

Postprandial Response of Individuals to Dietary Inorganic Phosphate

Cardiovascular Risk Factor

Germany
Martin-Luther-Universität Halle-Wittenberg
German Federal Ministry of Education and Research

Completed

Effect of Vitamin D3 on Cardiovascular Risk Factors

Hypertensive Disease | Deficiency of Vitamin D3
Martin-Luther-Universität Halle-Wittenberg
German Federal Ministry of Education and Research

Completed

Study on the Effects of a Recommendation Based Supply of Vitamin D3 in Healthy Volunteers

Deficiency of Vitamin D3

Germany
OBELAB, Inc.
Helptrial Inc.

Not yet recruiting

Evaluation of rSO2 Between Frontal Lesion Area and Normal Area of Brain by NIRSITX Using NIRS in Acute Ischemic Stroke Patients.

Acute Ischemic Stroke Patients

Korea, Republic of
Athersys, Inc
Medpace, Inc.

Recruiting

MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study (MASTERS-2)

Ischemic Stroke

United States, Taiwan
89bio, Inc.
ProSciento, Inc.

Completed

A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH

NASH

United States, Puerto Rico
ModernaTX, Inc.
Aetion, Inc.

Active, not recruiting

Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran

SARS-CoV-2

United States
Eisai Inc.
Quintiles, Inc.

Terminated

FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal Cancer

Colorectal Cancer

United States, Australia, Russian Federation, India, Ukraine
AxeroVision, Inc.
ORA, Inc.

Completed

A Study to Evaluate AXR-159 Ophthalmic Solution in Patients With Dry Eye Disease

Dry Eye

United States
Versartis Inc.

Completed

Long-Acting Growth Hormone in Children Compared to Daily rhGH (VELOCITY)

Growth Disorders
Novan, Inc.
Synteract, Inc.

Completed

A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatment of MC (B-SIMPLE1)

Molluscum Contagiosum

United States
EmitBio Inc.

Completed

Phase I/II Safety, Dose Finding & Antiviral Activity of RD-X19 in Mild/Moderate Outpatient COVID-19

COVID19

United States
Xoft, Inc.
Icad, Inc.

Withdrawn

An Efficacy Study of the Xoft® Axxent® eBx® IORT System® "Lite"

Ductal Carcinoma In Situ | Invasive Ductal Carcinoma
Versartis Inc.

Completed

Versartis Trial in Children to Assess Long-Acting Growth Hormone (VERTICAL)

Pediatric Growth Hormone Deficiency

United States

Clinical Trials Sponsored by Ulthera, Inc

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations